chartexchange

Veracyte (VCYT) Securities Investigation Notice - Levi & Korsinsky

PR Newswire | Nov 12, 2026 10:09 AM EST

Needham reportedly cut its Veracyte price target by $23 per share after the Company's November 4, 2026 outlook reset on its Decipher Prostate test. An investigation into potential securities law violations is underway on behalf of VCYT shareholders who lost money. NEW YORK, Nov. 12, 2026...

Read original article